XML 19 R7.htm IDEA: XBRL DOCUMENT v3.22.4
CONSOLIDATED STATEMENTS OF CHANGES IN TOTAL EQUITY - USD ($)
shares in Thousands, $ in Thousands
Total
Impact of new accounting pronouncements
Common Shares
Capital in Excess of Stated Value
Accumulated Other Comprehensive Loss
Retained Earnings
Retained Earnings
Impact of new accounting pronouncements
Non- controlling Interests
Beginning Balance at Dec. 31, 2019 $ 1,815,705 $ (209) $ 7,175 $ 310,778 $ (816,803) $ 2,301,532 $ (209) $ 13,023
Beginning Balance (in shares) at Dec. 31, 2019     100,198          
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Net income (loss) 207,241         207,463   (222)
Other comprehensive (loss)/income:                
Translation gain/(loss) 46,092       47,970     (1,878)
Defined benefit plan adjustment [1] 11,666       11,666      
Derivative financial instruments [1] 325       325      
Other comprehensive income/(loss) 58,083       59,961     (1,878)
Dividends paid to noncontrolling interests 0            
Dividends (173,570)         (173,570)    
Issuance of stock awards 1,154     1,154        
Issuance of stock awards (in shares)     398          
Shares repurchased (8,483)     (8,483)        
Shares repurchased (in shares)     (149)          
Stock-based compensation 10,607     10,607        
Ending Balance at Dec. 31, 2020 1,910,528   $ 7,175 314,056 (756,842) 2,335,216   10,923
Ending Balance (in shares) at Dec. 31, 2020     100,447          
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Net income (loss) (82,711)         (85,477)   2,766
Other comprehensive (loss)/income:                
Translation gain/(loss) (75,636)       (75,052)     (584)
Defined benefit plan adjustment [1] 471,350       471,350      
Derivative financial instruments [1] 1,119       1,119      
Other comprehensive income/(loss) 396,833       397,417     (584)
Dividends paid to noncontrolling interests (1,009)             (1,009)
Dividends (179,734)         (179,734)    
Issuance of stock awards 1,111     1,111        
Issuance of stock awards (in shares)     309          
Shares repurchased (218,085)     (218,085)        
Shares repurchased (in shares)     (3,386)          
Stock-based compensation 22,608     22,608        
Ending Balance at Dec. 31, 2021 $ 1,849,541   $ 7,175 119,690 (359,425) 2,070,005   12,096
Ending Balance (in shares) at Dec. 31, 2021 97,370   97,370          
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Net income (loss) $ 466,980         466,437   543
Other comprehensive (loss)/income:                
Translation gain/(loss) (68,780)       (69,240)     460
Defined benefit plan adjustment [1] 424       424      
Derivative financial instruments [1] (1,842)       (1,842)      
Other comprehensive income/(loss) (70,198)       (70,658)     460
Purchase of noncontrolling interest (13,196)     (7,080)       (6,116)
Dividends (188,259)         (188,259)    
Issuance of stock awards 1,167     1,167        
Issuance of stock awards (in shares)     354          
Shares repurchased (4,547)     (4,547)        
Shares repurchased (in shares)     (79)          
Stock-based compensation 31,309     31,309        
Ending Balance at Dec. 31, 2022 $ 2,072,797   $ 7,175 $ 140,539 $ (430,083) $ 2,348,183   $ 6,983
Ending Balance (in shares) at Dec. 31, 2022 97,645   97,645          
[1] net of tax